LNTH — Lantheus Holdings Share News
0.000.00%
Last trade - 00:00- $7.15bn
- $7.22bn
- $1.54bn
Brief: Lantheus To Acquire Life Molecular Imaging For An Upfront Payment Of $350 Mln
Brief: Radiopharm Theranostics Says Lantheus Increases Shareholding In Co
Australia's Radiopharm Theranostics rises on partnership with Lantheus
Brief: Lantheus Holdings Inc Enters First Amendment To Credit Agreement
Brief: Lantheus Holdings Inc - Jeff Humphrey No Longer Cmo At Lantheus Holdings
Lantheus Holdings rises after it announces $250 mln share repurchase program
Brief: Lantheus Authorizes $250 Mln Stock Repurchase Program
U.S. RESEARCH ROUNDUP-BXP, Hubspot, Qualcomm
Brief: Lantheus Reports Third Quarter 2024 Financial Results
Brief: Lantheus Holdings Q3 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.56
Brief: Lantheus Holdings Expects To Release Data In Oct 2024 For Splash Trial Based On 75% Of Protocol-Specified Target Overall Survival Events Being Reached
Brief: Lantheus Presents Results From The Primary Analysis Of Phase 3 Pivotal Splash Trial
Brief: Lantheus Appoints Julie Eastland As New Board Member
Lantheus Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Lantheus Holdings Q2 Adjusted EPS USD 1.8 Vs. IBES Estimate USD 1.83
Lantheus Holdings Inc expected to post earnings of $1.83 a share - Earnings Preview
Brief: Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
U.S. RESEARCH ROUNDUP-Corecivic, Eli Lilly, Wd-40
Lantheus gains on CMS's reimbursement rule for diagnostic radiopharmaceuticals